These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21055830)

  • 1. Oral health and the symptoms of schizophrenia.
    Arnaiz A; Zumárraga M; Díez-Altuna I; Uriarte JJ; Moro J; Pérez-Ansorena MA
    Psychiatry Res; 2011 Jun; 188(1):24-8. PubMed ID: 21055830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of oral health in the adult population from ages 35-44 in Poland].
    Lichota D
    Ann Acad Med Stetin; 1998; 44():263-83. PubMed ID: 9857544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
    Bralet MC; Yon V; Loas G; Noisette C
    Encephale; 2000; 26(6):32-41. PubMed ID: 11217537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral health and treatment needs of institutionalized chronic psychiatric patients in Istanbul, Turkey.
    Gurbuz O; Alatas G; Kurt E; Issever H; Dogan F
    Community Dent Health; 2010 Sep; 27(3):151-7. PubMed ID: 21046906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of the dental health of chronic institutionalized patients with psychiatric disease in Israel.
    Zusman SP; Ponizovsky AM; Dekel D; Masarwa AE; Ramon T; Natapov L; Grinshpoon A
    Spec Care Dentist; 2010; 30(1):18-22. PubMed ID: 20051070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia.
    Woon PS; Chia MY; Chan WY; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):463-8. PubMed ID: 20109511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disordered eating attitudes in Egyptian antipsychotic naive patients with schizophrenia.
    Fawzi MH; Fawzi MM
    Compr Psychiatry; 2012 Apr; 53(3):259-68. PubMed ID: 21640339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral health in people over 64 years of age, institutionalized in Centres for the Aged in the Vigo Health District Spain, 2005.
    Iglesias Corchero AM; García Cepeda JR
    Med Oral Patol Oral Cir Bucal; 2008 Aug; 13(8):E523-8. PubMed ID: 18667989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oral health status of dentate patients with chronic renal failure undergoing dialysis therapy.
    Bots CP; Poorterman JH; Brand HS; Kalsbeek H; van Amerongen BM; Veerman EC; Nieuw Amerongen AV
    Oral Dis; 2006 Mar; 12(2):176-80. PubMed ID: 16476040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oral health status of patients on oral bisphosphonates for osteoporosis.
    Kunchur R; Goss AN
    Aust Dent J; 2008 Dec; 53(4):354-7; quiz 366. PubMed ID: 19133952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP; Spina E; Murray S; Yang R
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients.
    Ritsner M; Maayan R; Gibel A; Strous RD; Modai I; Weizman A
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):267-73. PubMed ID: 15163435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reexamination of the characteristics of the deficit schizophrenia patients.
    Tiryaki A; Yazici MK; Anil AE; Kabakçi E; Karaağaoğlu E; Göğüş A
    Eur Arch Psychiatry Clin Neurosci; 2003 Oct; 253(5):221-7. PubMed ID: 14504990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral health status and practices of dentate Bhil adult tribes of southern Rajasthan, India.
    Kumar TS; Dagli RJ; Mathur A; Jain M; Balasubramanyam G; Prabu D; Kulkarni S
    Int Dent J; 2009 Jun; 59(3):133-40. PubMed ID: 19637521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z; Britvić D; Vuković O; Ille T
    Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone in first-episode schizophrenia.
    Cesková E; Prikryl R; Kaspárek T
    Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.